Nurse Practitioner and Physician Assistant Buprenorphine Prescription Practices Survey
This research study is a part of a larger project that aims to train physicians, nurse practitioners (NPs), and physician assistants (PAs) in prescribing buprenorphine, a medication that is used to treat patients with opioid use disorders. This research study aims to gather information to better understand knowledge, attitudes and perceived barriers regarding buprenorphine for medication assisted treatment (MAT) in New York State.
You will complete a web-based or paper-and-pencil survey that is securely submitted/returned to us. It is a one-time, anonymous survey that can be completed at a time and place of your convenience. We expect that you will be in this research study for less than 20 minutes. The research consists of a single, brief survey.
Compensation is not available for this study.
The aim of the study is to gather information to better understand NPs and PAs knowledge, attitudes, and perceived barriers regarding the use of buprenorphine for medication assisted treatment (MAT) in New York State. Survey questions pertain to: interest in prescribing buprenorphine for MAT, their perceived barriers and challenges, their needs to enable them to prescribe buprenorphine in their practice, and stigma-related concerns. The survey will be offered to NPs and PAs who are (or soon will be) eligible to prescribe buprenorphine in New York State.
NPs and PAs who practice in New York State and have received or are eligible to receive a waiver to prescribe buprenorphine
Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the
contact information above or email firstname.lastname@example.org and someone will assist you.
Your information will be shared only with the research study team for recruitment purposes and designated CTSI personnel for project quality
assurance and will remain confidential. Your information will be stored indefinitely. Should you no longer want this information to be provided
in the aforementioned ways, please contact email@example.com.